S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|GTx to Present Results on Enobosarm 9mg in Women with Metastatic Breast Cancer at 2014 San Antonio Breast Cancer Symposium (2014/12/8)|
|OncoGenex Announces Results from the Phase 2 Borealis-1™ Trial of Apatorsen in the Treatment of Metastatic Bladder Cancer (2014/12/19)|
|Ipsen’s Somatuline® Depot® is the First Therapy Approved by the FDA in the United States for the Treatment of Patients with Locally Advanced or Metastatic Gastroenteropancreatic Neuroendocrine Tumors (2014/12/16)|
|Three New Myriad Studies Highlighted at 2014 San Antonio Breast Cancer Symposium (2014/12/9)|
|Exelixis Announces Results from the COMET-2 Pivotal Phase 3 Trial of Cabozantinib in Men With Metastatic Castration-Resistant Prostate Cancer (2014/12/1)|
|Cerulean Announces Publication Describing Synergistic Anti-Tumor Activity of CRLX101 with Avastin in Advanced Metastatic Ovarian Tumor Models (2015/1/6)|
|Pfizer Marks World Cancer Day with Grant to Union for International Cancer Control to Address the Needs of Metastatic Breast Cancer Patients (2015/2/4)|
|New Survey Finds Majority of Women with Breast Cancer Who Work Want to Do So Even While Undergoing Treatment (2014/12/2)|
|FoundationOne® Identifies Clinically Relevant Genomic Alterations in Patients with Advanced Breast Cancers (2014/12/9)|
|Exelixis and Swedish Orphan Biovitrum AB (Sobi) Extend and Restructure Distribution Agreement for COMETRIQ® for Medullary Thyroid Cancer (2015/1/7)|
Click above to view more mutual fund data and stats for mtst - MetaStat Inc.